Discontinuation report PEGETRON
| Report ID | 5746 |
| Drug Identification Number | 02246030 |
| Brand name | PEGETRON |
| Common or Proper name | ribavirin plus peginterferon alfa-2b, Powder for Solution in Vials |
| Company Name | MERCK CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | PEGINTERFERON ALFA-2B RIBAVIRIN |
| Strength(s) | 150MCG 200MG |
| Dosage form(s) | CAPSULE POWDER FOR SOLUTION |
| Route of administration | ORAL SUBCUTANEOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | vial |
| ATC code | L03AB |
| ATC description | IMMUNOSTIMULANTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2017-04-04 |
| Actual discontinuation date | 2017-04-04 |
| Remaining supply date | 2017-04-04 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2017-04-05 | French | Compare |
| v1 | 2017-04-05 | English | Compare |
Showing 1 to 2 of 2